SAB BIOTHERAPEUTICS, INC. (SABS) Total assets 2020–2025
SAB BIOTHERAPEUTICS, INC. (SABS) total assets at each fiscal year-end, per SEC filings.
$172.8MFY2025 · since FY2020: $56.5M → $172.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $172.8M | +291.0% |
| FY2024 | $44.2M | -47.3% |
| FY2023 | $83.9M | +64.9% |
| FY2022 | $50.9M | -37.3% |
| FY2021 | $81.1M | +43.5% |
| FY2020 | $56.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More SABS financial trends
SABS RevenueSABS Net incomeSABS Net marginSABS Gross profitSABS Gross marginSABS Operating incomeSABS Operating marginSABS Operating cash flowSABS Free cash flowSABS Capital expendituresSABS Return on equitySABS Stock buybacksSABS Dividends paidSABS Total liabilitiesSABS Shareholders’ equitySABS overview →